Lucis combines lab testing, wearable data, and health insights to help individuals understand and improve their biology.
Lucis has raised $8.5M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
Lucis's investors include General Catalyst, Y Combinator, Singular, Rebel Fund, Kima Ventures.
Lucis is headquartered in Artannes-sur-indre, France.
Lucis combines lab testing, wearable data, and health insights to help individuals understand and improve their biology.
Lucis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lucis — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/lucis. Accessed July 19, 2026.
VCBacked. (2026). Lucis — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/lucis
{{cite web |title=Lucis — Funding & Investors |url=https://www.vcbacked.co/company/lucis |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated